Occult hepatitis B in HIV-HCV coinfected patients

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 10, 2008, Pages 835-839

  Piroth, Lionel ^a   Lafon, Marie Edith ^b   Binquet, Christine ^a   Bertillon, Pascale ^c   Gervais, Anne ^d   Lootvoet, Enguerrand ^c   Lang, Jean Marie ^e   Jaureguiberry, Jean ^f   Chene, Genevieve ^c   Leport, Catherine ^d  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d BICHAT HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f Service des Maladies Infectieuses   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CD4 CD8 RATIO; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OCCULT HEPATITIS B; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS REACTIVATION;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 52349084688     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540801918511     Document Type: Article

References (22)

1. Chemin, I. and Trepo, C. (2005) Clinical impact of occult HBV infections. J Clin Virol, 34, p. S15.
2. Nunez, M., Rios, P., Perez-Olmeda, M. and Soriano, V. (2002) Lack of 'occult' hepatitis B virus infection in HIV infected patients. AIDS, 16, pp. 2099-2101.
3. Neau, D., Winnock, M., Jouvencel, A., Faure, M., Castera, L. Legrand, E. et al. (2005) Occult hepatitis B virus infection in HIV infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis, 40, pp. 750-753.
4. Rodriguez-Torres, M., Gonzalez-Garcia, J., Brau, N., Sola, R., Moreno, S. Rockstroh, J. et al. (2007) Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection: Clinically relevant or a diagnostic problem?. J Med Virol, 79, pp. 694-700.
5. Gandhi, R., Wurcel, A., McGovern, B., Lee, H., Shopis, J. Corcoran, C. et al. (2003) Low prevalence of ongoing hepatitis B viraemia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr, 34, pp. 439-441.
6. Pogany, K., Zaaijer, HL, Prins, JM, Wit, FW, Lange, JM and Beld, MG. (2005) Occult hepatitis B virus infection before and 1 y after start of HAART in HIV type-1-positive patients. AIDS Res Hum Retroviruses, 21, pp. 922-926.
7. Quarleri, J., Moretti, F., Bouzas, M., Laufer, N., Carrillo, M. Giuliano, S. et al. (2007) Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-co-infected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses, 23, pp. 525-531.
8. Santos, EA, Yoshida, CF, Rolla, VC, Mendes, JM, Vieira, IF Arabe, J. et al. (2003) Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type-1. Eur J Clin Microbiol Infect Dis, 22, pp. 92-98.
9. Shire, NJ, Rouster, SD, Rajicic, N. and Sherman, KE. (2004) Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr, 36, pp. 869-875.
10. Re, VL III, Frank, I., Gross, R., Dockter, J., Linnen, JM Giachetti, C. et al. (2007) Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr, 44, pp. 315-320.
11. Drosten, C., Nippraschk, T., Manegold, C., Miesel, H., Brixner, V. Roth, WK et al. (2004) Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. J Clin Virol, 29, pp. 59-68.
12. Piroth, L., Binquet, C., Vergne, M., Minello, A., Livry, C. Bour, J. et al. (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol, 36, pp. 681-686.
13. Wagner, A., Denis, F., Weinbreck, P., Loustaud, V., Autofage, F. Rogez, S. et al. (2004) Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS, 18, pp. 569-571.
14. Mphahlele, MJ, Lukhwareni, A., Burnett, RJ, Moropeng, LM and Ngobeni, JM. (2006) High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol, 35, pp. 14-20.
15. Filippini, P., Coppola, N., Pisapia, R., Scolastico, C., Marrocco, C. Zaccariello, A. et al. (2006) Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS, 20, pp. 1253-1260.
16. Jilg, W., Sieger, E., Zachoval, R. and Schatzle, H. (1995) Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: High percentage of carriers of hepatitis B and C virus. J Hepatol, 23, pp. 14-20.
17. Hofer, M., Joller-Jemelka, H., Grob, P., Luthy, R. and Opravil, M. (1998) Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis, 17, pp. 6-13.
18. Chemin, I., Baginski, I., Petit, M., Zoulim, F., Pichoud, C. Capel, F. et al. (1991) Correlation between HBV DNA detection by polymerase chain reaction and pre-S1 antigenaemia in symptomatic and asymptomatic hepatitis B virus infection. J Med Virol, 33, pp. 51-57.
19. Wagner, AA, Loustaud-Ratti, V., Chemin, I., Weinbreck, P., Denis, F. and Alain, S. (2005) Double hepatitis B virus infection in a patient with HIV/hepatitis C virus coinfection and 'anti-HBc alone' as serological pattern. Eur J Clin Microbiol Infect Dis, 24, pp. 623-627.
20. Torres-Baranda, R., Bastidas-Ramirez, BE, Maldonado-Gonzalez, M., Sanchez-Orozco, JV, Vasquez-Vals, E. Rodriguez-Noriega, E. et al. (2006) Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction. Ann Hepatol, 5, pp. 34-40.
21. Shire, NJ, Rouster, SD, Stanford, SD, Blackard, JT, Martin, CM Fichtenbaum, CJ et al. (2007) The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr, 44, pp. 309-314.
22. Lacombe, K., Massari, V., Girard, PM, Serfaty, L., Gozlan, J. Pialoux, G. et al. (2006) Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS, 20, pp. 419-427.